- CMS published the premium totals for Medicare on June 21, 2026.
- Medicare pricing negotiations are impacting major pharmaceutical companies, including AbbVie, Eli Lilly, and Merck, who are seeking pricing exemptions.
- Medicare negotiates volume discounts on drugs, while lobbying efforts block government cost-trimming.
The pharmaceutical industry is pushing a narrative against the 340B drug pricing program.
1 report, 1 independent
Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The pharmaceutical industry is pushing a narrative against the 340B drug pricing program.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Medicare
US federal health insurance